首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 0 毫秒
1.
细胞因子在急性移植物抗宿主病中的作用   总被引:3,自引:2,他引:3  
急性移植物抗宿主病(aGVHD)是异基因造血干细胞移植的主要发症,严重限制其应用。细胞因子网络在aGVHD的发病中起重要作用,其作用机制在小鼠模型中已经得到清楚的阐述,而类aGVHD的发病机制尚需进一步探讨。动态监测移植后血清细胞因子sIL-24,TNF-α和IFN-γ等的表达或检测移植前细胞因子的基因表达可以对aGVHD进行预测,从而有助于采取针一的预防措施。GVHD有移植物抗白血病作用(GVL)。GVHD和GVL是可分的,细胞因子IL-2,IL-12,IL-11,KGF和G-CSF有降低GVHD保存GVL的作用。  相似文献   

2.
白细胞介素-18在急性移植物抗宿主病发病机制中的作用   总被引:4,自引:0,他引:4  
为了研究异基因外周血造血干细胞(allo—PBSCT)移植期细胞因子白细胞介素—18(IL—18)与急性移植物抗宿主病(aGVHD)的关系,以探讨IL—18在aGVHD发病中的作用,对26例恶性血液病患进行了allo—PBSCT,并采用双夹心酶联免疫吸附法(ELISA)检测移植前及移植后aGVHD发生时患外周血单个核细胞分泌的IL—18浓度。结果表明:移植患中10例发生I度GVHD和5例发生Ⅲ—Ⅳ度GVHD,发生aGvHD患分泌的IL—18浓度显高于未发生aGVHD患,并又IL—18浓度与aGVHD的严重程度成正相关,与感染的发生无关。结论:IL—18在aGVHD的发病中起重要的作用。  相似文献   

3.
本研究应用雷公藤多甙防治小鼠急性移植物抗宿主病。对受致死量照射的C57BL/6受鼠,注入供鼠BABC/c骨髓与脾淋巴细胞的混合液,并给予雷公藤多甙、环孢素A、甲氨蝶呤处理。用免疫组织化学法、流式细胞术和ELISA法检测各组小鼠T淋巴细胞、黏附分子、细胞因子。结果表明:所有异基因对照组小鼠,在30天内死于aGVHD,而雷公藤多甙组(19/21)、环孢素A+甲氨蝶呤组(13/21)和雷公藤多甙+环孢素A组(17/21)的大部分小鼠存活时间超过了30天,并没有明显的aGVHD症状表现。雷公藤多甙、环孢素A、甲氨蝶呤可明显降低皮肤、肺组织CD3^+、CD4^+、CD8^+、CD11a^+、CD18^+细胞(P〈0.05)和脾组织CD3^+,CD4^+,CD8^+,CD4^+CD11a^+,CD4^+CD18^+。CD8^+CD11a^+,CD8^+CD18^+细胞(P〈0.05)。而小肠组织CD3^+、CD4^+、CD8^+细胞变化不明显(P〉0.05)。同时,雷公藤多甙可降低受鼠血清中IL-2、TNFα浓度和脾组织IL-2、TNFα的mRNA的表达(P〈0.05);上调血清中IL-10的水平(P〈0.05)。但对IL-4的作用不显著(P〉0.05)。结论:雷公藤多甙具有明显抗aGVHD作用并同时保留抗白血病效应,其作用机制与调节促炎/抑炎细胞因子的分泌和黏附分子的表达,以及抑制T淋巴细胞作用有关。  相似文献   

4.
移植后早期免疫重建与急性移植物抗宿主病关系的研究   总被引:2,自引:1,他引:2  
为了分析异基因造血干细胞移植(allo-HSCT)后的早期淋巴细胞重建与急性移植物抗宿主病(aGVHD)之间的关系。本研究对26例恶性血液病患行allo-HSCT,移植后2个月内采用流式细胞术检测淋巴细胞亚群CD3^ ,CD4^ ,CD8^ ,CD25^ ,CD69^ 细胞的变化。所有患均获得造血重建,9例发生Ⅰ度GVHD,5例发生Ⅱ-Ⅳ度GVHD。CD25^ 细胞在aGVHD发生组于移植后第2周上升,第3周达峰值,早于aGVHD的症状出现,与疾病的严重程度显相关,随症状的缓解而下降。实验结果提示,分析患移植后的早期免疫重建可以预测aGVHD的发生。CD25^ 细胞在aGVHD发生之前明显上升,是预测aGVHD的指标。  相似文献   

5.

Background

Growing numbers of allogeneic stem cell transplants and improved posttransplant care have led to an increase of individuals with chronic graft-versus-host disease (cGVHD). Although cGVHD leads to functional impairment for many, there is limited literature regarding the benefits of acute inpatient rehabilitation for patients with cGVHD.

Objective

To assess Functional Independence Measure (FIM) outcomes of patients with cGVHD during acute inpatient rehabilitation and to compare inpatient rehabilitation outcomes with patients with burn injuries, a rehabilitation patient population with similar comorbidities.

Design

Retrospective chart review.

Setting

Acute rehabilitation center at a large academic medical center.

Patients (or Participants)

A total of 37 adult patients with cGVHD and 30 with burn injuries admitted to inpatient rehabilitation from 2010 to 2015.

Methods or Interventions

Linear regression analysis to evaluate group (cGVHD versus burn) differences in functional gains. Effect size and minimal detectable change at the 90% confidence level (MDC90) were used to evaluate change in FIM outcomes.

Main Outcome Measurements

Total FIM gain, motor FIM gain, and FIM efficiency.

Results

Patients with cGVHD had statistically significant lower functional gains than patients with burn injuries, with an average of 11.66 fewer total FIM points (P ≤ .001), 10.54 fewer motor FIM points (P = .01), and 2.45 units less of FIM efficiency (P = .01). At the time of discharge, 7 (18%) patients with cGVHD exceeded the MDC90 values for total FIM gain versus 9 (30%) patients with burn injuries (P = .26). Eight (21%) patients with cGVHD exceeded the MDC90 for motor FIM gain versus 13 (43%) patients with burn injuries (P = .048). Effect sizes for patients with cGVHD and with burn injury were moderate to large, respectively, with patients with burn injuries having nearly twice the magnitude of gains as patients with cGVHD.

Conclusions

Despite achieving more modest functional gains than patients with burn injuries, patients with cGVHD improved in function after acute inpatient rehabilitation. If replicated in larger studies, patients with functional impairment from cGVHD can be considered for inpatient rehabilitation. Future work should also determine minimal clinically important differences in function gain from inpatient rehabilitation for patients with cGVHD.

Level of Evidence

II  相似文献   

6.
7.
We conducted a study to examine prevalence, predictors, and concomitants of acute stress disorder (ASD) following diagnosis of cancer among 89 patients. In addition to other measures, each participant completed the Stanford Acute Stress Reaction Questionnaire (SASRQ). One-third (33%) of the sample met all ASD symptom criteria. Significantly more women than men met criteria for ASD. For women, predictors for ASD symptoms included being of a younger age, having no prior life-threatening illness, perceiving less social support from friends, and reporting less satisfaction with how the diagnosis got communicated to them. A statistical trend was evident between higher religious/spiritual commitment and fewer ASD symptoms. For men, no factors were significantly related to ASD symptoms. Overall among cancer patients, those who met symptom criteria for ASD reported significantly more impulsive spending, desire to run away to avoid contact with people, giving away personal belongings, thinking about suicide, and forgetting medical information following cancer diagnosis than did cancer patients who did not meet criteria for ASD.  相似文献   

8.
本研究探讨高压氧(HBO)在抗异基因骨髓移植后aGVHD和提高生存率中的作用及机制。给受致死量照射的C57BL/6受鼠注入供鼠BALB/c骨髓与脾淋巴细胞的混合液,分别给与高压氧、环孢素A、氨甲蝶呤处理。用流式细胞仪检测脾T细胞及其亚群和黏附分子CD3^+、CD4^+、CD8^+、CD4^+CD11a^+、CD4^+CD18^+、CD8^+CD11a^+、CD8^+CD18^+的表达,用ELISA和RT-PCR法检测细胞因子IL-2、IL-4、IL-10和TNFα的表达。结果表明:HBO组小鼠11天的活存率明显高于异基因移植组及CsA+MTX组;HBO和CsA+MTX可明显降低脾组织中CD3^+、CD4^+、CD8^+、CD4^+CD11a^+、CD4^+CD18^+、CD8^+CD11a^+、CD8^+CD18^+的表达(P〈0.05);HBO组小鼠血清IL-2和TNFα的浓度及脾组织中IL-2和TNFα mRNA的含量都低于异基因骨髓移植组(P〈0.05),但高于CsA+MTX组;HBO组小鼠脾组织中IL-4和IL-10 mRNA的含量显著高于异基因骨髓移植组和CsA+MTX组(P〈0、05)。结论:高压氧在对抗aGVHD和提高活存率方面优于环孢素A和氨甲蝶呤,其抗aGVHD的作用机制与调节促炎/抑炎细胞因子的分泌和黏附分子的表达及抑制T淋巴细胞作用有关。  相似文献   

9.
Chronic liver disease has been reported to be an important causeof late morbidity and mortality in renal transplant recipients.We have examined the prevalence and nature of chronic liverdisease among 538 patients with functioning renal allograftsmanaged at the Western Infirmary, Glasgow, between 1980 and1989. Thirty-seven patients (7 per cent) satisfied biochemicalcriteria for chronic liver dysfunction. Liver biopsies wereobtained from 24 of these, and autopsy tissue was availablefrom three other patients. Chronic hepatitis of variable severitywas present in 15 patients, haemosiderosis in 12 patients andnodular regenerative hyperplasia in five patients. Nineteenpatients (51 percent) had serological evidence of infectionwith the hepatitis C virus, and one of these developed chronichepatitis B and D infection as well. Although a variety of chronicliver diseases occurred in our transplant population, the frequencyof serious sequelae from liver dysfunction was much lower thanthat reported from transplant centres in other countries.  相似文献   

10.
本研究评价供者CCR5在经过强化预处理的骨髓移植动物模型受者体内的作用,为今后的异基因造血干细胞移植的临床应用提供科学依据.经过致死剂量照射的BALB/c小鼠接受异基因C57BL/6小鼠的骨髓移植.根据回输的细胞不同实验分为4组:B6 CCR5 KO组,受者接受C57BL/6 CCR5-/-小鼠骨髓和脾脏细胞;B6 WT组,受者接受野生型C57BL/6小鼠骨髓和脾脏细胞;B6 CCR5 KO BMC组,受者只接受C57BL/6 CCR5-/-小鼠骨髓细胞;B6 WT BMC组,受者只接受野生型C57BL/6小鼠骨髓细胞.结果表明:较之B6 WT组,B6 CCR5 KO组小鼠以更快的速度死于急性GVHD;其受者体内的CD8+T细胞更大量的增殖;其T细胞恢复后产生更多的INF-γ和TNF-α并且由于其T细胞有丝分裂原刀豆素水平处于较高水平,从而进一步促进T细胞的增殖,提示CCR5的作用之一是下调参与排异反应的供者CD8+T细胞的增殖.组织学评价提示,移植剔除CCR5基因受者细胞的小鼠肾脏出现了病理损伤并且肝脏存在有更为严重的病理变化.结论:剔除CCR5基因的异基因骨髓移植使GVHD发病率的增加,供者CD8+T细胞在受者体内增殖增加以及肝肾损害加重,这提示CCR5在异基因骨髓移植中起着重要作用.  相似文献   

11.
慢性移植物抗宿主病(cGVHD)是异基因造血干细胞移植后晚期并发症中最为常见的一种。该病严重影响移植的成功。本综述cGVHD发病机制、诊断、预防和治疗的研究进展。  相似文献   

12.
本研究评价供者CCR5在经过强化预处理的骨髓移植动物模型受者体内的作用,为今后的异基因造血干细胞移植的临床应用提供科学依据。经过致死剂量照射的BALB/c小鼠接受异基因C57BL/6小鼠的骨髓移植。根据回输的细胞不同实验分为4组:B6CCR5KO组,受者接受C57BL/6CCR5^-/-小鼠骨髓和脾脏细胞;B6WT组,受者接受野生型C57BL/6小鼠骨髓和脾脏细胞;B6CCR5KOBMC组,受者只接受C57BL/6CCR5^-/-小鼠骨髓细胞;B6、WT BMC组,受者只接受野生型C57BL/6小鼠骨髓细胞。结果表明:较之B6、WT组,B6CCR5KO组小鼠以更快的速度死于急性GVHD;其受者体内的CD8^+T细胞更大量的增殖;其T细胞恢复后产生更多的INF-γ和TNF-α并且由于其T细胞有丝分裂原刀豆素水平处于较高水平,从而进一步促进T细胞的增殖,提示CCR5的作用之一是下调参与排异反应的供者CD8^+T细胞的增殖。组织学评价提示,移植剔除CCR5基因受者细胞的小鼠肾脏出现了病理损伤并且肝脏存在有更为严重的病理变化。结论:剔除CCR5基因的异基因骨髓移植使GVHD发病率的增加,供者CD8^+T细胞在受者体内增殖增加以及肝肾损害加重,这提示CCR5在异基因骨髓移植中起着重要作用。  相似文献   

13.
14.
J. Tegoli    J. P. Harris    M. E. Nichols    W. L. Marsh    M. E. Reid 《Transfusion》1970,10(3):133-136
A patient who received a liver transplant subsequently developed autologous anti‐I and anti‐M. The antibodies were demonstrated in the serum and in eluates from the patient's red blood cells, and could be separated by cross‐absorption with appropriate red blood cells. The patient received horse antilymphocyte globulin and the possibility could not be excluded that the anti‐M was transferred passively.  相似文献   

15.
本文报道1例AML—M2a患者在造血干细胞移植中服用环孢素A(CSA)诱发急性胰腺炎并进行临床分析。1例49岁急性髓性白血病(AML-M2a)患者,在进行同胞HLA相合造血干细胞移植术后20天并发急性胰腺炎。预处理方案采用改良Bu/Cy方案,移植物抗宿主病(GVHD)预防包括环孢菌素A(CsA)、短程甲氨蝶呤(MTX)及抗胸腺细胞球蛋白(ATG)。结果表明:尽管患者腹部CT及彩超检查均显示胰腺无异常,但临床及实验室检查均支持急性胰腺炎的诊断。经过全身支持治疗及CsA减量患者最终得以缓解。结论:CsA是导致急性胰腺炎的可能诱因。  相似文献   

16.
目的:探讨肝脏恶性病变的CT表现及其诊断价值。材料与方法:回顾性分析经手术病理证实的101例肝脏恶性病变的CT资料。结果:结节型肝癌28例、巨块型肝癌15例,弥漫型肝癌9例,小型肝细胞癌1例,末梢型胆管癌1例,肝门型胆管癌1例,肝胆管囊腺癌1例,肝转移瘤45例。结论:肝脏恶性病变具有一定的临床和CT特征。CT对肝脏各种恶性病变的诊断及鉴别诊断有重要价值。  相似文献   

17.
自身抗体在肝病患者诊断中的意义   总被引:2,自引:0,他引:2  
目的探讨肝病患者血清中是否出现自身抗体及该抗体与疾病的关系。方法收集肝病患者血清,以HEP-2细胞、鼠肝和猴肝组织切片和可溶性肝抗原为抗原基质,用间接免疫荧光法、蛋白质印迹法检测肝病患者血清中的自身抗体。结果①间接免疫荧光法检测自身抗体显示:慢性肝炎、肝硬化、肝癌三组阳性率分别为22.3%(29/130),30.9%(30/97),34.1%(14/41),它们之间无显著性差异(P>0.05),但三组阳性率与急性肝炎(7.0%)、正常对照组(1.5%)比较有显著性差异(P<0.01)。②蛋白质印迹法检测肝特异性自身抗体靶抗原时发现慢性肝炎、肝硬化患者约66.0%,的抗原相对分子质量多集中在47kD及52kD上,两组抗原条带分布相似,有30.0%的肝硬化、肝癌患者在20kD及32kD分子质量之间的阳性条带上、下处多出现1~2条无对应条带。结论慢性肝炎、肝硬化、肝癌患者血清中自身抗体的阳性率明显高于急性肝炎和正常对照组。患者血清中存在抗肝组织自身抗体,其相对应的靶抗原有多种,如能进一步鉴定靶抗原有望成为诊断肝脏疾病的免疫学标志物。  相似文献   

18.
目的:探讨肝脏各种良性病变的CT表现及其诊断价值.材料与方法:回顾性分析经手术病理证实的163例肝脏良性病变的CT资料.结果:肝胆管囊腺瘤1例,肝脏血管瘤38例,肝细胞腺瘤1例,肝脏脂肪瘤1例,肝脏血管平滑肌脂肪瘤1例,局灶性结节增生1例,炎性假瘤1例,肝脏囊肿45例,细菌性肝脓肿32例,肝脏炎性肉芽肿1例,肝脏结核1例,肝脏包虫40例.结论:肝脏各种良性病变具有一定的临床和CT特征.CT对肝脏各种良性病变的诊断及鉴别诊断有重要价值.  相似文献   

19.
20.
慢性肝病肝纤维化的诊断   总被引:1,自引:0,他引:1  
肝纤维化是指在各种慢性肝病时,肝细胞发生持续、反复的坏死或炎症刺激,导致机体发生修复反应,结果是大量纤维增生同时伴有纤维降解相对或绝对不足,细胞外基质在肝内大量沉积。肝纤维化的及时早期诊断和治疗,对于肝病诊治有重要价值。一个合理完整的肝纤维化的诊断模式应包括临床、病理组织学、影像学、血清生化标志物的综合诊断。长期以来肝活检一直是诊断肝纤维化的“金标准”,也是其他无创性肝纤维化诊断试验的参考标准,但肝活检有创伤性,在临床实践中不仅一次肝穿较难获得,二次肝穿更难实现。无创性诊断中,肝纤维化并无特殊的临床症状和体征,单项的血清生化指标检测诊断的敏感性和特异性还很差,影像学检查缺乏特异性,血清生化标志物数学诊断模式FibroTest虽有较好的诊断准确性,但其计算颇为复杂而难以普及推广。迄今尚无充足的证据证明可取代肝穿的“金标准”,因此如何均衡各种指标的利弊。筛选最佳组合,简化计算步骤,降低费用,减少肝穿,寻找新的更特异敏感的标志物,仍是我们今后所要努力的。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号